Skip to main content
Equibles
PEN logo

PEN · Penumbra Inc · Metrics

Track PEN — free

Use PEN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PEN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$317.55 -0.45 (-0.14%) At close · Oct 2
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$12.56B
Shares
39.39M
Volume · Oct 2 239.68K Avg daily vol (3M) 342.99K

PEN metrics

76 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$317.55
Market cap
$12.56B

Price action

20 metrics
Price change (1W)
-0.4%
Price change (30D)
-1.1%
Price change (3M)
-0.3%
Price change (6M)
-3.9%
Price change (YTD)
+2.1%
Price change (1Y)
+25.3%
Trailing year
Price change (5Y)
+20.7%
52-week high
$359.40
52-week low
$225.54
Change from 52-week high
-11.6%
Change from 52-week low
+40.8%
Annualized volatility
28.1%
Annualized volatility (3M)
6.1%
Beta
0.0
RSI (14D)
39.3
Price vs SMA 50
-1.3%
Price vs SMA 200
-2.8%
Avg volume (3M)
342,992
Relative volume
0.7
Average dollar volume
$109.81M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
39.39M

Valuation

12 metrics
P / E (TTM)
78.0
Trailing earnings · reciprocal yield 1.3%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
8.3×
reciprocal yield 12.0%
P / book
8.2
reciprocal yield 12.2%
FCF yield
1.7%
TTM · current market cap
Buyback yield
—
P / FCF
58.2
reciprocal yield 1.7%
P / operating cash flow
45.2
reciprocal yield 2.2%
Earnings yield
1.3%

Historical valuation

8 metrics
P / E historical average (3Y)
223.5×
reciprocal yield 0.4%
P / E historical average (5Y)
413.3×
reciprocal yield 0.2%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-30

Profitability

9 metrics
Gross margin
67.8%
Operating margin
12.4%
Trailing 12 months
Net margin
10.7%
Gross profit (TTM)
$1.02B
Operating profit (TTM)
$187.34M
Net income (TTM)
$160.59M
Trailing 12 months
Diluted EPS (TTM)
$4.07
FCF margin
14.3%
Effective tax rate
21.2%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$36.39

Growth

11 metrics
Revenue growth YoY
+14.9%
Year over year
Net income growth YoY
-23.1%
Revenue (TTM)
$1.50B
Trailing 12 months
EPS growth YoY
-23.5%
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+18.3%
Revenue CAGR (5Y)
+20.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
10.5%
Return on assets
8.1%
Debt / equity
—
Current ratio
5.7
EBITDA (TTM)
$204.48M
Free cash flow (TTM)
$215.91M
Quick ratio
3.9
Interest coverage
144.3
Net debt / EBITDA
-1.0
Return on invested capital
—
Trailing 12 months
Net cash
$205.27M
Latest balance sheet
Cash & equivalents
$205.27M
Total assets
$1.97B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$277.80M
Capital expenditures (TTM)
$61.90M
R&D (TTM)
$92.25M
SG&A (TTM)
$741.31M
Stock compensation (TTM)
$59.50M
R&D / revenue
6.1%
Stock compensation / revenue
4.0%

Ownership (13F)

3 metrics
13F filers
454
13F filer change QoQ
-31
Institutional ownership
88.7%

Short interest

3 metrics
Short interest
4.6%
Latest settlement · 7.2 days to cover
Days to cover
7.2d
Short-squeeze score
65 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1321732 CUSIP 70975L107 13F (30d) 14 filings 12 filers Visit website Investor relations